Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs Williams Companies Inc (WMB) Price & Performance

NeoGenomics Inc. Common StockTrade
Williams Companies IncTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs Williams Companies Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Williams Companies Inc trades at $72.47 (market cap $91.21B). The key difference: Williams Companies Inc is far larger — about 42.6× NeoGenomics Inc. Common Stock's market cap, and Williams Companies Inc pays a 2.82% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Williams Companies Inc for 58 Days on average.

NEOWMB
Market Cap
$2.14B$91.21B
Volume
2,228,4006,950,661
Sector
HealthEnergy
52-Week High
$19.91$79.40
52-Week Low
$7.19$56.51
Typical Hold Time
0 Days58 Days
Enterprise Value
$2.44B$121.84B
Dividend Yield
—2.82%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Williams Companies Inc

Williams Companies (WMB) trades at $72.80, down 1.85% on the day, with strong technical momentum indicated by bullish moving averages. The company maintains robust profitability with 25.18% net income margin and 24.02% ROE, supported by $5.9B operating cash flow in 2025. Recent earnings show mixed results with Q1 2026 beating expectations while Q4 2025 and Q2 2026 missed. The stock benefits from positive analyst sentiment with 79% buy ratings and $87.08 consensus price target, representing 20% upside potential.

WMB presents a compelling investment case with strong dividend growth, exposure to rising natural gas demand from AI data centers, and resilient midstream business model. Key risks include energy market volatility, high debt levels at $24.74B long-term debt, and execution challenges in capital-intensive projects. The stock's valuation at 29.71 P/E appears reasonable given growth prospects, but investors should monitor debt management and energy price sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
WMB
0% Buy100% Sell
Avg holding period · 58 Days

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About Williams Companies Inc

Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.

Read more on WMB →